A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 8, Issue 2, 2009, Pages 143-149

  Laine, Larissa ^a   Perry, John D ^a   Lee, Jenner ^a   Oliver, Michelle ^a   James, Arthur L ^b   De La Foata, Corinne ^c   Halimi, Diane ^c   Orenga, Sylvain ^c   Galloway, Angela ^a   Gould, F Kate ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NORTHUMBRIA UNIVERSITY   (United Kingdom)

^c BIOMÉRIEUX   (France)

Author keywords

Culture media; Cystic fibrosis; Enzyme substrates; Pseudomonas aeruginosa; Respiratory infection

Indexed keywords

AGAR; AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TEMOCILLIN; TIMENTIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE;

ADOLESCENT; ADULT; AGAR; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; CYSTIC FIBROSIS; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSEUDOMONAS AERUGINOSA; SPUTUM; YOUNG ADULT;

EID: 60749113675     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2008.11.003     Document Type: Article

References (23)

1. Gilligan PH, Kiska DL, Appelman MD. Cumitech 43, Cystic fibrosis microbiology. Coordinating ed., Appelman M.D. ASM Press, Washington, D.C., 2006.
2. Ratjen F., Döring G., and Nikolaizik W.H. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 358 (2001) 983-984
3. Döring G., Conway S.P., Heijerman H.G., Hodson M.E., Høiby N., Smyth A., et al., for the Consensus Committee. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Resp J 16 (2000) 749-767
4. Lee B., Haagensen J.A.J., Ciofu O., Andersen J.B., Høiby N., and Molin S. Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43 (2005) 5247-5255
5. Kodaka H., Iwata M., Yumoto S., and Kashitani F. Evaluation of a new agar medium containing cetrimide, kanamycin and nalidixic acid for isolation and enhancement of pigment production of Pseudomonas aeruginosa in clinical samples. J Basic Microbiol 43 (2003) 407-413
6. Van Pelt C., Verduin C.M., Goessens W.H.F., Vos M.C., Tümmler B., Segonds C., et al. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol 37 (1999) 2158-2164
7. Wellinghausen N., Köthe J.K., Wirths B., Sigge A., and Poppert S. Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43 (2005) 4070-4075
8. Zaytsev A.V., Anderson R.J., Bedernjak A., Groundwater P.W., Huang Y., Perry J.D., et al. Synthesis and testing of chromogenic phenoxazinone substrates for ß-alanyl aminopeptidase. Org Biomol Chem 6 (2008) 682-692
9. Campbell M.E., Farmer S.W., and Speert D.P. New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethyamino)phenyl]-9,10-dihydro-10-phenylacridine hydrochloride (C-390). J Clin Microbiol 26 (1988) 1910-1912
10. Brown A.R., and Govan J.R.W. Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples. J Clin Microbiol 45 (2007) 1920-1926
11. da Silva Filho L.V., Levi J.E., Oda Bento C.N., da Silva Ramos S.R., and Rozov T. PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients. J Med Microbiol 48 (1999) 357-361
12. Andrews J.M. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48 Suppl 1 (2001) 5-16
13. Fuchs P.C., Barry A.L., Thornsberry C., and Jones R.N. Interpretive criteria for temocillin disk diffusion susceptibility testing. Eur J Clin Microbiol 4 (1985) 30-33
14. T.D.V. Swinscow, Statistics at Square One (9th Edition) BMJ Publishing Group [Online] Available at: http://www.bmj.com/statsbk/index.dtl (Accessed: 26 March 2008).
15. De Vos D., de Chial M., Cochez C., Jansen S., Tümmler B., Meyer J.M., et al. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175 (2001) 384-388
16. Reyes A.E.P., Bale M.J., Cannon W.H., and Matsen J.M. Identification of Pseudomonas aeruginosa by pyocyanin production on Tech agar. J Clin Microbiol 13 (1981) 456-458
17. Daly J.A., Boshard R., and Matsen J.M. Differential primary plating medium for enhancement of pigment production by Pseudomonas aeruginosa. J Clin Microbiol 19 (1984) 742-743
18. Spilker T., Coenye T., Vandamme P., and LiPuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol 42 (2004) 2074-2079
19. Qin X., Emerson J., Stapp J., Stapp L., Abe P., and Burns J.L. Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 41 (2003) 4312-4317
20. Xu J., Moore J.E., Murphy P.G., Millar B.C., and Elborn J.S. Early detection of Pseudomonas aeruginosa - comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob 3 (2004) 21
21. Hogardt M., Trebesius K., Geiger A.M., Hornef M., Rosenecker J., and Heesemann J. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol 38 (2000) 818-825
22. Perry J.D., and Freydière A.M. The application of chromogenic media in clinical microbiology. J Appl Microbiol 103 (2007) 2046-2055
23. Foweraker J.E., Laughton C.R., Brown D.F.J., and Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact in the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 55 (2005) 921-927